RecruitingNCT06798324
Brain stimulation added to varenicline for smoking cessation
About this title
Read the official source — NCT06798324Medication studyAges 18–85CanadaAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 85 years.
- Listed locations
- TorontoSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 10, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 160
- Sponsor
- Centre for Addiction and Mental Health
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Device, Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- From 18 Years to 85 Years
- Official registry ID
- NCT06798324
- Official title
Show the full official title
Using Non-Invasive Brain Stimulation (tDCS) as an Adjunct to Varenicline for the Treatment of Tobacco Dependence: a Randomized Controlled Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Varenicline 1mg BID.
Who can participate?
Listed age limits: 18 years to 85 years.
Is this study still recruiting?
The registry lists this study as recruiting.
